Boyle Scott N

CIK 00019138971 companyWATERTOWN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001913897

Recent Transactions

34 trades

Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2026-02-14$1.89/sh−7,269→ 298,801 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2026-02-14+20,950→ 306,070 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2026-02-13$1.89/sh−1,735→ 306,070 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2026-02-13+5,000→ 307,805 total
Award
C4 Therapeutics, Inc.$CCCC
Common Stock
2026-02-13+200,000→ 307,805 total
Sale
C4 Therapeutics, Inc.$CCCC
Common Stock
2025-02-18$3.15/sh−669→ 107,805 total
Award
C4 Therapeutics, Inc.$CCCC
Common Stock
2025-02-14+56,500→ 111,332 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2025-02-14+84,700→ 84,700 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2025-02-14$3.18/sh−2,368→ 108,474 total
Sale
C4 Therapeutics, Inc.$CCCC
Common Stock
2025-02-14$3.15/sh−490→ 110,842 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2025-02-13$3.20/sh−1,735→ 54,832 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2024-11-07$6.04/sh−1,102→ 56,567 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2024-11-07+3,750→ 57,669 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Performance Restricted Stock Units
2024-11-07−3,750→ 10,500 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2024-09-16$6.36/sh−661→ 53,919 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2024-09-16+2,250→ 54,580 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Performance Restricted Stock Units
2024-09-16−2,250→ 14,250 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2024-03-07+115,000→ 115,000 total
Disposition to Issuer
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2024-03-07−115,000→ 0 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2024-02-14+122,800→ 122,800 total
Award
C4 Therapeutics, Inc.$CCCC
Common Stock
2024-02-14+27,300→ 52,330 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2024-02-13$6.53/sh−1,735→ 25,030 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2023-09-18+120,000→ 120,000 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Performance Restricted Stock Units
2023-08-30−2,250→ 16,500 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2023-08-30+2,250→ 27,426 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2023-08-30$2.93/sh−661→ 26,765 total
Award
C4 Therapeutics, Inc.$CCCC
Common Stock
2023-02-13+20,000→ 25,176 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2023-02-13+90,000→ 90,000 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2023-01-30+3,750→ 6,398 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2023-01-30$7.78/sh−1,222→ 5,176 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Performance Restricted Stock Units
2023-01-30−3,750→ 18,750 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2022-05-26$7.01/sh−1,102→ 2,648 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2022-05-25+3,750→ 3,750 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Performance Restricted Stock Units
2022-05-25−3,750→ 22,500 total

Companies

C4 Therapeutics, Inc.
Chief Business Officer
$CCCC

Recent Filings

Address

C/O C4 THERAPEUTICS, INC. 490 ARSENAL WAY #120

WATERTOWN, MA, 02472

View on SEC.gov